In this study, we investigated the production of endothelin 1 (ET-1) by a human microvascular endothelial cell line, HMEC-1, co-cultured with Plasmodium falciparum-parasitized red blood cells (pRBCs). The results indicate that hypoxia increased the basal level of ET-1 production by HMEC-1 cells after 24 or 48 h of treatment. However, the co-incubation of HMEC-1 cells with pRBCs, but not with uninfected RBCs, induced a dose-dependent decrease of both constitutive and hypoxia-induced ET-1 production. The inhibition was not due to a decrease in cell viability, as lactate dehydrogenase release remained constant. These results indicate that pRBCs are able to interfere with both the constitutive and stimulated ET-1 release from the microvascular endothelium, thus inducing local modifications of the vascular tone and of the inflammatory response. This could be of relevance in the pathogenesis of the most severe forms of P. falciparum infections, such as cerebral malaria or malaria during pregnancy.
INTRODUCTION
Endothelins (ETs) are involved in the regulation of vascular tone, in the amplification of the inflammatory response, as well as in normal cell proliferation, repair and tissue development [1] . Produced predominantly by the endothelium in response to a variety of stimuli including cytokines (interleukin 1, tumour necrosis factor α, transforming growth factor β), and, notably, hypoxia [2] , ET-1 can in turn modulate the endothelial expression of adhesion molecules and cytokines production [3] [4] . ET-1 levels are elevated in pathological conditions such as ischemia-reperfusion injury and sepsis [1] . Little is known of the role of ET-1 in malaria and, in particular, in the pathogenesis of severe falciparum malaria that is characterized by multiple organ dysfunction and occurs most commonly in African children, causing up to 1.5 million deaths annually [5] . The pathogenesis of complicated malaria (cerebral malaria, renal failure or malaria Key words : endothelin-1, hypoxia, malaria, Plasmodium falciparum.
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Correspondence : Dr N. Basilico (e-mail nicoletta.basilico!unimi.it). during pregnancy) involves massive cytokine release and cytoadherence of parasitized red blood cells (pRBCs) to the microvasculature that leads to a mechanical blockage of microvessels causing local hypoxia, increased permeability and the expression of specific cytoadherence receptors (intercellular adhesion molecule 1, CD36) [6] . Against this background, and considering that big-ET-1 levels are reportedly high in severe malaria [7] , we wanted to investigate the production of ET-1 by pRBC-treated microvascular endothelium under normal or hypoxic conditions.
MATERIALS AND METHODS

Cell cultures
Microvascular endothelial (HMEC-1) cells immortalized by simian-virus-40 large T antigen [8] were provided by Dr F. J. Candal, Center for Disease Control, Atlanta, 
Plasmodium falciparum culture
In vitro cultures of P. falciparum strain D10 were maintained at 5 % haematocrit (human A-positive RBCs) at 37 mC in RPMI 1640 medium (GIBCO-BRL) supplemented with 10 % heat-inactivated human plasma\ 20 mM Hepes, in a standard gas mixture consisting of
Stimulation of HMEC-1 cells with P. falciparum-infected erythrocytes
Asynchronous P. falciparum cultures with a parasitaemia ranging from 3 % to 6 % were used on HMEC-1 cells. In some experiments, trophozoite-and schizont-enriched preparations were obtained at higher parasitaemia (up to 20 %) using a Percoll gradient. pRBCs were diluted at 1 % haematocrit and added to confluent monolayers of HMEC-1 cells in 96-well flat-bottomed microplates (Costar Italia, Milan, Italy). Uninfected RBCs were used as controls. Cells were incubated for 24 or 48 h at 37 mC, in normoxic condition (5 % CO 
ET-1 and lactate dehydrogenase (LDH) assays
The levels of ET-1 in supernatants were assayed using the human ET-1 enzyme immunometric assay kit (Assay Designs, Inc., Ann Arbor, MI, U.S.A.). LDH levels were detected using the SYNCRON CX7D system (Beckman Analytical, Fullerton, CA, U.S.A.) and the LD-P kit (Beckman Coulter, Fullerton, CA, U.S.A.).
Statistical analysis
All the tests were performed at least three times in quadruplicate and the results were analysed by one-way analysis of variance.
RESULTS
After 24 h of incubation in complete medium and in normoxic (20 % O # ) conditions, HMEC-1 cells constitutively produced 35.3p8.6 pg\ml of ET-1. When hypoxic conditions (1 % O # ) were used as the stimulus, the production of ET-1 increased to 61.1p12.7 pg\ml (152p30.8 % of the controls). Figure 1 shows the results of a representative experiment out of five performed in the same conditions.
Co-culture of HMEC-1 cells with pRBCs, but not with uninfected RBCs, induced a dose-dependent decrease of both constitutive and hypoxia-induced ET-1 production (Figure 1 ). On average, in five different experiments, co-incubation with pRBCs (4.5 % parasitaemia) inhibited constitutive and hypoxia-induced ET-1 production by 31.8p19 % (range 13-59 %) and 44.8p4 % (range 38-49 %) respectively. At the highest parasitaemia used (20 %), the release of ET-1 decreased by 77p15.2 % in normoxic conditions and by 82p11 % in hypoxic conditions. In all the experiments, cell morphology and viability were not affected. The release of LDH was not significantly different in control HMEC-1 cells or in RBC-or pRBC-treated monolayers (Figure 1 ). The inhibition of ET-1 production was still evident after 48 h of co-culture of HMEC-1 cells with pRBCs (results not shown).
DISCUSSION
We report here that the constitutive production of ET-1 by HMEC-1 cells was increased by hypoxia, but was reduced significantly in both normoxic and hypoxic conditions by pRBCs in a concentration-dependent manner. The increase in ET-1 production in hypoxic conditions is consistent with previous reports, which showed that hypoxia increases ET-1 levels in cultured human endothelial cells, through the activation of the transcription factor HIF-1 (hypoxia-inducible factor 1) [9] . As an in vitro system, we used simian-virus-40-immortalized HMEC-1 cells, which retain most of the morphological, phenotypic and functional characteristics of normal human microvascular endothelial cells [8] . It has also been used to measure cytoadherence of pRBCs to microvascular endothelium [10] . To our knowledge this is the first report that HMEC-1 cells, as is the case with endothelial cells from different tissues, produce ET-1 in response to hypoxia.
When HMEC-1 cells were treated with pRBCs at different levels of parasitaemia, but not with uninfected RBCs, a dose-dependent inhibition of ET-1 production was observed. At present, it is not clear whether whole pRBCs or isolated parasite products affect the functions of endothelial cells. A good candidate could be haemozoin, malaria pigment, the detoxification product of haemoglobin-derived haem that it is known to exert an immunoregulatory role [11] [12] [13] . Preliminary results indicated that the inhibition of ET-1 production by isolated pigment was less than with whole pRBCs, suggesting that other parasite products, in addition to haemozoin, can contribute to the inhibition of ET-1 production by HMEC-1. Our results seem different from the reported increase of plasma big-ET-1 in complicated malaria [7] . However, plasma levels may not truly reflect the situation in the microvasculature where a large number of parasites adhere and accumulate (sequestration). Increased ET-1 could contribute to the reduction of cerebral blood flow, and to endothelial activation via up-regulation of adhesion molecule expression, as reported for cerebral malaria [6] . However, as parasitaemia increases, the consequent inhibition of ET-1 production could increase local vasodilatation and cell vulnerability. The inhibition of ET-1 production may be part of an amplification loop leading to intense vasodilatation in scattered microvascular areas where the parasites are sequestered.
